IM96 CAR-T cell therapy

· Beijing Immunochina Medical Science & Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IM96 CAR-T cell therapy, covering 2024-12-05 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction [Phase 1]

See pricing